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Background: Diffusely reflected light is influenced by cytologic and morphologic changes that take place during
tissue transformation, such as, nuclear changes, extracellular matrix structure and composition as well as blood flow.
Albeit with varying degree of sensitivity and specificity, the properties of diffusely reflected light in discriminating a
variety of oral lesions have been demonstrated by our group in multiple studies using point monitoring systems.
However, the point monitoring system could not identify the region with the most malignant potential in a
single sitting.
Methods: In order to scan the entire lesion, we developed a multi-spectral imaging camera system that records
diffuse reflectance (DR) images of the oral lesion at 545 and 575 nm with white light illumination. The diagnostic
accuracy of the system for 2-dimensional DR imaging of pre-malignant and malignant changes in the oral cavity
was evaluated through a clinical study in 55 patients and 23 healthy volunteers. The DR imaging data were
compared with gold standard tissue biopsy and histopathology results.
Results: In total 106- normal/clinically healthy sites, 20- pre-malignant and 29- malignant (SCC) sites were
compared. While the median pixel value of the R545/R575 image ratio for normal/clinically healthy tissue was 0.87
(IQR = 0.82-0.94), they were 1.35 (IQR = 1.13-1.67) and 2.44 (IQR = 1.78-3.80) for pre-malignant and malignant lesions,
respectively. Area under the ROC curve to differentiate malignant from normal/clinically healthy [AUC = 0.99
(95% CI: 0.99-1.00)], pre-malignant from normal/clinically healthy [AUC = 0.94 (95% CI: 0.86-1.00)], malignant from
pre-malignant [AUC = 0.84 (95% CI: 0.73-0.95)] and pre-malignant and malignant from normal/clinically healthy
[AUC = 0.97 (95% CI: 0.94-1.00)] lesions were desirable.
Conclusion: We find DR imaging to be very effective as a screening tool in locating the potentially malignant areas
of oral lesions with relatively good diagnostic accuracy while comparing it to the gold standard histopathology.
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Oro-pharyngeal cancer is a major component of the glo-
bal cancer burden [1,2]. Early detection of pre-malignant
changes facilitates timely adoption of preventive mea-
sures and treatment strategies [3]. The potential benefi-
cial effect of early detection and treatment may improve
the survival rates in patients with cancer of the oral
cavity [4]. The gold standard for diagnosis of oral cavity
cancer is an invasive tissue biopsy and histopathology
examination. However, detection of the potentially
malignant site for biopsy is visually challenging even for
experienced clinicians, which often leads to multiple
biopsies and delay in diagnosis.
Toluidine blue staining [5] and direct fluorescence
visualization [6,7] have been used in clinical settings as
an adjunctive visual tool to enhance the contrast
between the clinical lesions and the adjacent normal oral
tissue. Diffusely reflected (DR) white light spectra were
also studied by various groups [8,9] for tissue differenti-
ation in oral cavity. Several multi-centric clinical studies
established the effectiveness of optical spectroscopy
techniques for non-invasive detection of oral malignan-
cies with good diagnostic accuracies [10-14]. However,
they are point monitoring systems that analyse the tissue
characteristics at a particular point in the entire area of
an oral lesion.
Several spectroscopic imaging techniques that rely
on tissue fluorescence have emerged recently for the
detection of oral malignancies [6,15-17]. Our previous
experience suggests that the diagnostic accuracies
based on DR spectroscopy are superior to fluorescence
spectroscopy in point monitoring systems. We there-
fore developed a multi-spectral diffuse reflectance im-
aging system for recording of DR images in vivo andFigure 1 Diffuse reflectance (DR) imaging set-up and image processin
(b) photo of the oral cavity of a patient with verrucous growth in the left c
and (d) 575 nm, (e) computed DR ratio (R545/R575) image and (f) pseudo
pixel intensity values for lesion discrimination.report the diagnostic accuracies of this system in com-
parison to the gold standard tissue biopsy and histo-
pathology examination.
Methods
Diffuse reflectance imaging system
The diffuse reflectance imaging system (DRIS) [18]
developed (Figure 1) for recording the monochrome
images of the oral cavity lesion at 545 and 575 nm in the
present study consisted of an electron multiplying
charge coupled device (EMCCD) camera (model:
LUCA-R, Andor Technology, UK) with 1024 × 1024
pixels of 8 micron size, coupled to a Nikkon AF 35–70
zoom lens for focusing and a liquid crystal tunable filter
(LCTF) of 7 nm bandwidth (CRI Inc., USA) for wave-
length selection. Suitable adapters were used to connect
the camera with the focusing lens and the LCTF, and
roller ball assemblies were built to facilitate camera
movement during focusing/zooming. The tungsten halo-
gen lamp (12 V, 55 W) that comes as standard white
light in dental chairs was used for illumination of oral
cavity during imaging. A laptop computer working with
the SOLIS program (Andor Technology, UK) controlled
the image acquisition parameters, recorded the images
sequentially at 545 and 575 nm and computed the ratio
image (R545/R575) arithmetically. The spatial distribu-
tion of the image ratio R545/R575 of the lesion was
displayed as a Pseudo Color Map (PCM) according to
the ratio value of each pixel in the image and based on
cut-off values derived from our previous studies [11-14]
with a point monitoring system. Thus, PCM classified
the oral lesion into blue (healthy tissue), red (dysplastic/
pre-malignant) and yellow (malignant tissue) colors,
thereby providing a visual discerning capacity to the eyeg. (a) Schematic of the diffuse reflectance imaging system (DRIS) and
ommissure, typical set of monochrome images recorded (c) at 545
colour mapped ratio image. Color palette shows the range of median
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with maximum potential to show dysplastic characteris-
tics and invasion.
Study settings and study measurements
The present study was conducted at the Oral and
Maxillofacial Pathology Department of the Government
Dental College (GDC), Trivandrum, after obtaining the
Ethical clearance from the GDC Ethics committee (No.
IEC/C/28-A/2010/DCT), and strictly adhering to the
approved protocols. Consecutive patients were invited to
participate in the study. Before enrollment, the study
subjects were asked to rinse their mouth with 0.9%
saline solution. A clinician then examined the oral cavity
of the patient for suspicious lesions, including white/red
patches, mixed white and red lesions, non-healing ulcers
and mucosal growth. The study procedures were
explained to the patient and written informed consent
was obtained from all participants before initiating any
study related measurements. All patients enrolled were
more than 20 years of age, and had no previous history
of cancer or radiation/ chemotherapy treatment, or used
any medication orally for the past seven days, and had
no life threatening medical condition. Patient details
were recorded and the clinical characteristics of the
lesions were noted by a qualified clinician. There was no
refusal to participate in the study. The DR imaging
system was used to capture monochrome images of all
suspected oral lesions at 545 and 575 nm. Tissue biop-
sies were taken from the region with maximum potential
to show dysplastic characteristics in a lesion as identified
by the PCM of the DR image ratio R545/R575. DR
images recorded from 13 different anatomical sites of
healthy volunteers were used as site-specific controls.
Tissue biopsy was not taken for healthy volunteers and
visual examination report of the pathologist was used for
categorization of the tissue as clinically healthy.
The biopsy samples were fixed in 10% formalin and
sent to the laboratory for pathological analysis. The
tissue samples were then dehydrated in ascending grades
of alcohol, embedded in paraffin block, micro-sectioned
using microtome and mounted on a thin glass plate.
This was then stained using haematoxylin and eosin
stains. Two oral pathologists, who were blinded to the
spectral measurement details, prepared the slides and
provided the histo-pathological results independently. ATable 1 Characteristics of study population categorized accor
Patient characteristics Normal/clinically healthy
Age (mean, SD) 27.5 (7.0)
Men (n, %) 17 (16.5)
Tobacco use (n, %) 1(1)
Alcohol use (n, %) 13 (12.6)third opinion was sought if there was any disagreement
between the two independent reports.
The DR image ratio was further analyzed based on the
mean pixel intensity of 100 pixels at 30 different points
within the proposed biopsy site. Median value of the
image ratio from these 30 points were determined and
used for classifying the lesions into three groups, viz.
normal/clinically healthy, pre-malignant or malignant
(squamous cell carcinoma: SCC). Oral lesions were clas-
sified according to the image ratio value R545/R575 and
the results were correlated with histo-pathologic findings
to determine the diagnostic accuracies.
Statistical analyses
The characteristics of the study population are summa-
rized as means and percentages. The DR spectral data
were compared across different tissue types based on the
histo-pathology findings using scatter plot. Receiver Oper-
ator Characteristics (ROC) curves were also constructed
using the DR spectral data to differentiate pre-malignant
from normal/clinically healthy tissue. The area under the
ROC curves (AUC) and its 95% CI were computed. The
statistical significance of AUC was tested using non-
parametric assumptions.
Results
All together 55 patients with oral lesions, such as
erythroplakia, leukoplakia, non-healing ulcers, and mu-
cosal growth, and 23 healthy volunteers as control were
enrolled for the study. The study was carried out from
April 2010 to December 2010. While the controls were
significantly younger than cases, tobacco use and alcohol
use were reported more frequently in cases than controls
(Table 1). Out of the 55 patients examined using DR
imaging, the pathology report showed that 6 lesions
were epithelial hyperplasias with no dysplasia, 20 lesions
were epithelial hyperplasia with different grades of
dysplasia (mild, moderate and severe), and 29 lesions
were malignant, which included well differentiated,
moderately differentiated and poorly differentiated SCCs
(Characteristics of the lesions are described in supplemen-
tary Additional file 1: Table S1). Epithelial hyperplasia with
no dysplasia were included in the group of healthy and
designated as normal/clinically healthy for analysis pur-
pose. A total of 100 sites were examined from 23 healthy
volunteers. Thus, the analysis was finally conducted byding to the grade of malignancy
Pre-malignant Malignant (cancer)
54.2 (12.0) 57.2 (10.5)
13 (59.1) 14 (42.4)
17 (77.3) 26 (78.8)
8 (36.4) 15 (45.5)
Figure 2 Imaging results of a typical malignant tongue lesion; (a) photograph of the traumatic ulcer on the right lateral border of the
tongue, (b) pathological investigation shows as well-differentiated SCC (WDSCC), (c) monochrome ratio image R545/R575 and (d) PCM
ratio image shows the most malignant area in light yellow.
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malignant (dysplasia) and 29- malignant (SCC) sites.
A non-healing ulcerated lesion in a 63 year old male
patient on the right lateral border of the tongue that was
present for more than two months is presented in
Figure 2 along with its monochrome and false colored
image ratios. While the bright yellow spot in the PCM
indicates malignancy, the histo-pathological analysis ofFigure 3 Imaging results of a typical pre-malignant lesion; (a) photog
(b) pathology shows severe dysplasia, (c) monochrome ratio image R
dysplastic region as red.the biopsy sample confirms the diagnosis of well diffe-
rentiated SCC (WDSCC).
By contrast, a lesion on the left lateral surface of the
tongue in a 43 year old male patient, clinically diagnosed
as speckled leukoplakia, histo-pathologically exhibits
severe dysplastic features (Figure 3). The PCM image of
this lesion shows red areas categorizing the lesion as
pre-malignant.raph of the lesion (leukoplakia on the LT of a 43 old male),
545/R575 and (d) PCM ratio image (R545/R575) shows severe
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image ratio for normal/clinically healthy tissue was
0.87 (IQR = 0.82-0.94), they were 1.35 (IQR = 1.13-1.67)
and 2.44 (IQR = 1.78-3.80) for pre-malignant and malig-
nant lesion, respectively. Scatter plots based on R545/
R575 image ratio are presented in Figure 4. While 1/29
malignant cases was misclassified as normal/clinically
healthy, 3/106 normal/clinically healthy lesions were mis-
classified as malignant at a mean pixel intensity cut-off of
1.1 (97% sensitivity and specificity). Similarly a cut-off of
1.01 (Figure 4b) miss-classified 1/20 pre-malignant cases
as normal/clinically healthy and 8/106 normal/clinically
healthy cases as pre-malignant (sensitivity of 95% and
specificity of 92%). While a cut-off at 1.66 (Figure 4c)Figure 4 Scatter plot diagram of pixel intensity values of the ratio im
malignant and normal/clinically healthy, (c) pre-malignant and malign
healthy. The cut-off lines for discrimination are drawn at the mean ratio vamisclassified 7/29 malignant lesions as pre-malignant and
4/20 pre-malignant lesions as malignant (sensitivity of
76% and specificity of 80%), a cut-off at 1.06 (Figure 4d)
misclassified 4/49 cancerous or pre-malignant cases as
normal/clinically healthy and 5/106 normal/clinically
healthy cases as cancerous or pre-malignant (sensitivity of
92% and specificity of 95%). Discordant findings of histo-
pathology and DR imaging results are presented in Table 2
with their detailed histopathology reports. Diagnostic
accuracies and positive and negative predictive values are
presented in Table 3. Area under the ROC curves
(Figure 5a-d) show the discriminatory capacity of the
image ratio to differentiate malignant from normal/cli-
nically healthy [AUC= 0.99 (95% CI: 0.99-1.00)], pre-age; (a) malignant and normal/clinically healthy, (b) pre-
ant and (d) malignant or pre-malignant and normal/clinically
lue of the groups classified.
Table 2 Discordant findings of histopathology and DR imaging results
Case
no
Clinical diagnosis Histopathological (microscopic examination) report DR image ratio result
5 Proliferative growth Tumor epithelial cells were seen invading into the underlying connective tissue in
the form of cords, islands, strands and nests. The invading cells exhibited features of
pleomorphism, hyperchromasia, increased nuclear to cytoplasmic ratio and abnormal
mitotic figures. Few keratin pearl formations were evident. Features suggestive
of MDSCC.
Normal
12 Verrucous growth Breach in the basement membrane was evident and tumor epithelial cells were seen
invading into the underlying connective tissue in the form of islands, strands and nests.
Keratin pearl formations were few. Tumor epithelial cells showed hyperchromasia,
increased nuclear to cytoplasmic ratio, pleomorphism and abnormal mitotic figures.
Features suggestive of MDSCC.
Normal
18 Non-specific ulcer The epithelium was hyperchromatic in the basilar one-third region. Dense chronic
inflammatory cells were seen within the connective tissue in the ulcerated region.
Features suggestive of epithelial hyperplasia with mild dysplasia.
Normal
23 Non-healing ulcer Epithelium exhibits no features of dysplasia. Moderate collections of chronic
inflammatory cells were seen in the juxta epithelial region. Features suggestive of
EHP with no dysplasia.
Pre-malignant
36 Ulcerated lesion with
keratotic border
Epithelium exhibits features of hyperchromasia, increased mitotic figures, increased
nuclear; cytoplasmic ratio, increased basilar hyperplasia involving two third of the
epithelium. Chronic inflammatory cells were moderately dispersed in the juxta
epithelial region. Features suggestive of EHP with moderate dysplasia.
Normal
39 Non-specific ulcer Basal and suprabasal cells exhibited hyperplasia and hyperchromasia. The inflammatory
cells were chronic and diffusely spread within the connective tissue. Features suggestive
of EHP with mild dysplasia.
Normal
MDSCC=moderately differentiated squamous cell carcinoma and EHP=epithelial hyperplasia.
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(95% CI: 0.86-1.00)], malignant from pre-malignant
[AUC= 0.84 (95% CI: 0.73-0.95)] and pre-malignant and
malignant from normal/clinically healthy [AUC = 0.97
(95% CI: 0.94-1.00)] lesions.
Discussion
The present study examines the diagnostic accuracy of a
spectral imaging system based on the principles of
diffuse reflectance in discriminating healthy oral tissue
from pre-malignant and malignant tissues. The diagnos-
tic accuracy obtained in this study is superior to other
imaging systems for detection of malignant changes in
the oral cavity.
When light interacts with biological tissue a small
portion of it is absorbed or transmitted while the rest
undergoes multiple elastic scattering due to heteroge-
neity in the refractive index of the tissue components
and gets diffusely reflected. Often, a portion of theTable 3 Diagnostic accuracies of DRIS in discriminating lesion
Lesion types Di
Sensitivity (%) Spe
Malignant Vs Normal 97
Pre-malignant Vs Normal 95
Pre-malignant Vs malignant 76
Malignant & Pre-malignant Vs Normal 92
PPV=positive predictive value, NPV=negative predictive value and ROC=receiver opimpinging radiation is reflected from the surface when
the roughness of the boundary is small in comparison
with the wavelength of light. The portion that penetrates
the sample gets scattered at a larger number of points in
its path due to uneven, broken or bumpy boundary
surfaces, where the coarseness is of the same order of
magnitude as the wavelength. During tissue transfor-
mation healthy tissue undergoes morphometric and
cytologic changes such as increase in epithelial thick-
ness, nuclear size, nuclear to cytoplasmic ratio, changes
in the chromatin texture and collagen content, and
angiogenesis [20-22]. These changes modify the diffusely
reflected component of the incoming radiation. We
hypothesized that the diffuse reflectance intensity
decreases during the transformation of tissue from
healthy to dysplastic due to morphologic, cytologic and
vascular changes associated with transformation. While
our previous studies supported this hypothesis and
differentiate pre-malignant and malignant tissue withs
agnostic accuracies Area under
the ROC curvecificity (%) PPV (%) NPV (%)
97 90 99 0.99
92 70 99 0.94
80 85 70 0.84
95 90 96 0.97
erator characteristics.
Figure 5 ROC curves showing the discriminatory capacity of the properties of ratio-image to differentiate; (a) malignant lesions from
normal/clinically healthy tissue, (b) pre-malignant lesions from normal/clinically healthy tissue, (c) pre-malignant lesions from
malignant and (d) malignant and pre-malignant from normal/clinically healthy tissue.
Figure 6 Scatter plot diagram of pixel intensity values for the
image ratio (R545/R575) discriminating malignant and
inflammatory areas.
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study findings further strengthens this relationship and
enables identification of areas with the most malignant
potential in an oral lesion.
Although the biological mechanisms associated with
changes in DR of different tissue types are not clear, one
potential possibility is associated with changes in
production of haemoglobin. In malignant tissues, the
haeme synthesis is disturbed due to the reduced activity
of the ferrochelatase enzyme [23] that results in lower
haemoglobin production and correspondingly lower
absorption at 545 and 575 nm of the oxygenated haemo-
globin spectra. A reduction in oxygenated haemoglobin
increases the DR ratio of R545/R575. Conversely, during
inflammatory conditions there is an increase in haeme
production, which leads to an enhancement in the
oxygenated haemoglobin and concomitant decrease in
the DR ratio of R545/R575 (Figure 6).
The diagnostic accuracies obtained in our study are
superior to the diagnostic accuracies obtained in studies
using direct tissue fluorescence visualization [6,16,17].
Unlike the present study, the discriminative capacity was
tested in a homogenous group of malignant lesions
consisting of mainly severe dysplastic tissues in all other
studies. The high diagnostic accuracy obtained in our
study underlines the potential use of this method inroutine clinical practice. However, we could not perform
site-specific analyses due to small number of cases in
each anatomical location. The diagnostic accuracies
presented in our study are therefore averaged for all
types of lesions of the oral cavity and it would have been
better if site-specific lesion classifications were possible.
The basis for our DR imaging method arises from the
differences in the spectra obtained from the normal and
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associated with tissue transformation from healthy to
pre-malignant/dysplastic and malignant. The imaging
method has the advantage of non-invasively scanning
the entire lesion and its surrounding areas in real-time,
and categorize oral lesions into normal/clinically healthy,
pre-malignant and malignant tissue. Furthermore, it effi-
ciently delineates the boundaries of neoplastic changes
and locates the site with most malignant potential for a
biopsy, thereby avoiding unnecessary repeated biopsies
and delay in diagnosis. Imaging the entire region may
also help the surgeons to identify the margins of the le-
sion that cannot be easily visualized by the naked eye
during surgical interventions. Applications of digital
image processing techniques may further enhance our
ability to objectively identify and delineate the peripheral
extent of neoplastic lesions.
Since clinical diagnosis based on DR imaging is pos-
sible in near real-time, there is practically no waiting
period for the patient. The method is relatively cheap
and can be implemented in all clinical settings with min-
imal training. Training the non-physician health workers
in the imaging technique and screening the patients for
tissue biopsy may further reduce the cost. However, the
cost-effectiveness of mass screening of oral lesions using
the imaging technique needs to be evaluated in different
settings before its wider adaptation. Furthermore, the
multi-spectral DR imaging technique presented in this
paper has the potential to be used as an adjunct to col-
poscopy in the screening of cervical pre-cancers and in
the identification the most malignant site for biopsy.
Further studies in a larger population may help us to de-
velop better classification algorithms for discriminating
dysplastic lesions as mild, moderate and severe, and
SCC lesions as ‘well differentiated’, ‘moderately differenti-
ated’ and ‘poorly differentiated’ tissue categories.
Conclusion
Diffuse reflectance spectral imaging technique efficiently
differentiates healthy tissue from pre-malignant and malig-
nant tissue in the oral cavity. The imaging system developed
for this study can be used as an adjunctive visual tool to
enhance the contrast between dysplastic tissue and normal
tissue in oral cavity lesions in clinical settings.
Additional file
Additional file 1: Table S1. Patient details with their clinical,
pathological and study results.
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